Anti-Inflammatory Effect of Blocking the Interaction Between Platelet Glycoprotein Ibα and the Leukocyte Integrin Αmβ2.

Qiang Han,Zhijie Li,Yuandong Peng,C. Wayne Smith,Jose A. Lopez
DOI: https://doi.org/10.1182/blood.v108.11.1632.1632
IF: 20.3
2006-01-01
Blood
Abstract:The interaction between the leukocyte integrin Mac-1 (α M β 2) and platelet glycoprotein (GP) Ibα allows leukocytes to firmly adhere to platelet thrombi, enabling their subsequent transmigration into the vessel wall. This interaction is blocked by the GP Ibα monoclonal antibody AP1, which we have previously mapped to the GP Ibα sequence Arg218 to Tyr228. In the current investigation we examined the effectiveness of a GP Ibα-based peptide containing the AP1 epitope in blocking platelet-leukocyte interactions under flow and in an inflammation model based on corneal wound healing. The peptide bound the α M I-domain specifically and saturably and was able to inhibit several GP Ibα-dependent functions under flow:
What problem does this paper attempt to address?